Alzheimer's Disease clinical trials
Showing 201–250 of 331 active trials. Describe your situation to see which ones you may be eligible for.
- Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's Disease
- δ in Dementia Clinical Trials
- Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer's Disease and Other Dementias 2.0
- Deep Repetitive Transcranial Magnetic Stimulation (rTMS) of the Precuneus for Alzheimer Disease (AD)
- Comparing Structured Retrieval Practice and Reading-Based Education for Dementia Caregivers
- Cardiac-Control Affecting Learning Through Mindfulness (CALM)
- Improving Access to Care for Veterans With Memory Loss
- The Role of the Locus Coeruleus in Age-related Distractibility
- Adapting RDAD for DS
- Intervention to Collect and Utilize Sexual Orientation and Gender Identity (SOGI) Information in Hospice
- Dementia Care Partner Hospital Assessment Tool
- Evaluating the Effectiveness of the Health App Recommendation Tool
- Palliative Care Education in Assisted Living for Dementia Care Providers (PCEAL-DCP)
- Senicapoc in Alzheimer's Disease
- Working Memory Training in Patients with Mild Cognitive Impairment
- Time Restricted Eating in Alzheimer's Disease
- Lifestyle Interventions for the Treatment of Early Onset Alzheimer's Disease Study
- I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
- Gamma-Music Based Intervention for Mild Alzheimer's Disease
- Dementia Caregivers' Link to Assistance and Resources
- Improving Memory in Alzheimer's Disease With Noninvasive Brain Stimulation
- ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease
- Testing the Effects of a Text Message Caregiver Support Intervention for Latinos
- A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- Olfactory Biopsies
- Improving PCP Advance Care Planning for People With ADRD
- Connect-Home: Alzheimer's Disease and Related Dementias
- Epidemiology and Biomarker Study in Alzheimer's Disease
- Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease
- Designing Care Management for Hospice Transitions for Persons Living With Advanced Dementia
- TMS for Cognitive Decline in Aging and Preclinical AD
- Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease
- A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
- Paper-Based and Smartphone-Based Memory Supports
- Tele-Savvy for Latino Caregivers
- Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging
- Evaluating the Efficacy of the Pain Identification and Communication Toolkit
- HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms
- Indian Transforming Alzheimer's Care Training (INTACT)
- Biomarker Exploration in Aging, Cognition and Neurodegeneration
- Music for Pain and Dementia
- Clinical Applications of Advanced Ophthalmic Imaging
- Using the EHR to Advance Genomic Medicine Across a Diverse Health System
- The Gut - PRO Study
- Epileptic Hippocampus in Alzheimer's Disease
- Personalized Closed-Loop Brain Stimulation for Patients With Primary Progressive Aphasia
- Personalized Closed-Loop Brain Stimulation for Patients With Mild Cognitive Impairment
- A Phase 2b/3 Clinical Study Evaluating T3D-959 in Mild-to-Moderate Alzheimer's Disease Subjects
- 2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients
- Mild Cognitive Impairment Community Screening and Early Intervention Via Stem Cell Therapy and Wearable Brain Computer Interface Device.
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.